San Diego, California — According to state and local economic development sources Guardant Health plans to invest $2,403,442.00 to build out 27,947 square feet of new space in San Diego. The company plans to occupy the new space at 10578 Science Center Dr Unit Bldg 1 L1 in San Diego, on or about July 1, 2021. According to the company website Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health Oncology Platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has launched liquid biopsy-based Guardant360 and GuardantOMNI tests for advanced stage cancer patients. These tests fuel development of its LUNAR program, which aims to address the needs of early stage cancer patients with neoadjuvant and adjuvant treatment selection, cancer survivors with surveillance, asymptomatic individuals eligible for cancer screening and individuals at a higher risk for developing cancer with early detection.

To learn more about Guardant Health, visit http://www.guardanthealth.com/

Company Contact:
Helmy Eltoukhy, Chief Executive Officer
https://www.linkedin.com/in/helmy-eltoukhy-b011855/
855-698-8887

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved